Grifols (GRFS) Minority Interest (2009 - 2020)
Grifols' (GRFS) quarterly Minority Interest came in at $2.1 billion in Q3 2020, up 255.46% YoY from $578.6 million in Q4 2019, and up 12.03% on a QoQ basis from $1.8 billion in Q1 2020.
Grifols (GRFS) Minority Interest (2009 - 2020) Analysis & Trends
Grifols (GRFS) has 12 years of Minority Interest data on file, last reported at $2.1 billion in Q3 2020.
- Quarterly Minority Interest rose 255.46% year-over-year to $2.1 billion in Q3 2020, while the trailing twelve-month figure through Sep 2020 was $2.1 billion (up 255.46% YoY) and the FY2019 annual result came in at $2.2 billion, up 316.62% from the prior year.
- Minority Interest rose to $2.1 billion in Q3 2020, from $1.8 billion in the prior quarter.
- In the past five years, Minority Interest ranged from a high of $2.2 billion in Q4 2019 to a low of $2.7 million in Q3 2018.
- A 5-year average of $605.3 million and a median of $7.0 million in 2016 frame the typical range for Minority Interest.
- Annual changes were most pronounced in 2016 — Minority Interest surged 113473.51% — and 2018, when it slipped 27.92%.
- Tracing GRFS's Minority Interest over 5 years: stood at $7.0 million in 2016, then declined by 17.99% to $5.8 million in 2017, then jumped by 9245.75% to $537.7 million in 2018, then jumped by 316.62% to $2.2 billion in 2019, then retreated by 8.18% to $2.1 billion in 2020.
- The last three Minority Interest figures came in at $2.1 billion (Q3 2020), $1.8 billion (Q1 2020), and $2.2 billion (Q4 2019), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.29 Bn | 631.53 Bn | 17.26 Bn |
| 2 | AbbVie | 470.62 Bn | 464.06 Bn | 12.70 Bn |
| 3 | Merck | 375.66 Bn | 368.52 Bn | 12.21 Bn |
| 4 | Novartis Ag | 302.90 Bn | 295.21 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.50 Bn | 252.60 Bn | 12.86 Bn |
| 6 | Amgen | 237.19 Bn | 223.20 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 182.92 Bn | 179.74 Bn | 6.22 Bn |
| 8 | Pfizer | 160.14 Bn | 148.44 Bn | 10.94 Bn |
| 9 | Gsk | 106.08 Bn | 101.91 Bn | 8.24 Bn |
| 10 | Grifols | 5.46 Bn | 4.46 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 2.06 Bn |
| Mar 31, 2020 | 1.84 Bn |
| Dec 31, 2019 | 2.24 Bn |
| Sep 30, 2019 | 578.62 Mn |
| Dec 31, 2018 | 537.65 Mn |
| Sep 30, 2018 | 2.73 Mn |
| Jun 30, 2018 | 4.59 Mn |
| Mar 31, 2018 | 584.68 Mn |
| Dec 31, 2017 | 5.75 Mn |
| Jun 30, 2017 | 6.36 Mn |
| Dec 31, 2016 | 7.01 Mn |
| Sep 30, 2016 | 4.51 Mn |
| Jun 30, 2016 | 4.69 Mn |
| Dec 31, 2015 | 5.69 Mn |
| Sep 30, 2015 | 5.15 Mn |
| Jun 30, 2015 | 4,126.60 |
| Mar 31, 2015 | 4.75 Mn |
| Dec 31, 2014 | 5.96 Mn |
| Sep 30, 2014 | 7.31 Mn |
| Jun 30, 2014 | 8.25 Mn |